Gossamer Bio Inc share price logo

Gossamer Bio Inc Share Price

NASDAQ: GOSS

Small Cap

$0.42

-0.03

(-6.82%)

as on

Gossamer Bio Inc Stock Performance

as on April 21, 2026 at 6:59 am IST

  • Day's High

    $0.42
    $0.46

    9.52%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.32
    $3.87
    downward going graph

    23.81%

    Downside

    821.43%

    Upside

    downward going graph

Gossamer Bio Inc share price movements today

Previous Close
$0.45
Open
$0.44
Volume
4.6M
Day's Low - High
$0.42 - $0.46
52 Week Low - High
$0.32 - $3.87

Gossamer Bio Inc Historical Returns

1 Month Return
-0.57 %
3 Month Return
-84.67 %
1 Year Return
-48.34 %
3 Year Return
-65.29 %
5 Year Return
-95.04 %

Gossamer Bio Inc Stock Fundamentals & Key Indicators

Check Gossamer Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$104.7M

EPS (TTM)

-0.489

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-163.2M

Revenue (TTM)

48.5M

Profit Margin

0.00%

Return On Equity TTM

-783.37%

Gossamer Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gossamer Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Gossamer Bio Inc image
Gossamer Bio Inc
BUY$104.7M-95.04%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B126.09%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.7B99.85%28.6532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.5BNA128.255.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B47.96%18.0531.41%

Stock Returns calculator for Gossamer Bio Inc Stock including INR - Dollar returns

The Gossamer Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Gossamer Bio Inc investment value today

Current value as on today

₹56,677

Returns

-₹43,323

(-43.32%)

Returns from Gossamer Bio Inc Stock

-₹48,148 (-48.15%)

Dollar Impact

₹4,825 (+4.83%)

Analyst Recommendation on Gossamer Bio Inc Stock

Based on 16 analysts

BUY

68.75%

Buy

31.25%

Hold

0.00%

Sell

Based on 16 analysts, 68.75% of analysts recommend a 'BUY' rating for Gossamer Bio Inc. Average target price of $3.69

Gossamer Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Gossamer Bio Inc.

What analysts predicted

88.62%UPSIDE

Target Price

$3.69

Current Price

$0.42

Analyzed by

16 Analysts

Target

$3.69

Gossamer Bio Inc target price $3.69, a slight upside of 88.62% compared to current price of $0.42. According to 16 analysts rating.

Gossamer Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Gossamer Bio Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-63% versus previous 30 day period

Gossamer Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
6
-
95
9
9
9
11
13
13
Gross Profit
-1
5
0
95
9
9
9
11
13
13
Operating Income
-40
-49
-41
52
-33
-36
-36
-38
-49
-46
EBITDA
-35
-43
-37
57
-28
-31
-33
-35
-45
-45
Interest Expense
3
3
3
2
2
2
2
2
2
2
Depreciation
1
1
0
0
1
1
0
0
0
0
Income Before Tax
-40
-48
-41
53
-31
-35
-36
-38
-48
-47
Income Tax Expense
6
-21
0
4
-1
-2
-
-
-
0
Net Income
-40
-48
-41
49
-30
-33
-36
-38
-48
-47
Net Profit Margin
0.00%
-709.73%
0.00%
51.37%
-324.93%
-352.16%
-370.49%
-333.13%
-362.73%
-342.33%

Gossamer Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
114
48
Gross Profit
-
-
0
-3
-4
-5
-4
-4
114
47
Operating Income
0
-6
-148
-186
-210
-216
-218
-183
-59
-163
EBITDA
0
-6
-148
-179
-226
-209
-211
-161
-39
-162
Interest Expense
-
0
0
-
12
19
13
13
11
10
Depreciation
-
-
0
3
4
5
4
4
4
1
Income Before Tax
0
-6
-146
-180
-243
-234
-229
-179
-55
-170
Income Tax Expense
0
-5
2
0
8
15
10
10
0
0
Net Income
0
-6
-146
-180
-243
-234
-229
-179
-56
-170
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-49.28%
-351.49%

Gossamer Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-48
-41
49
-30
-33
-36
-38
-48
-47
Operating Cash Flow
-33
-52
116
-32
-35
-39
-47
-36
-48
Investing Cash Flow
-14
61
-59
-26
53
22
44
17
73
Financing Cash Flow
-2
-2
-9
0
-
0
0
1
3
Change in Cash
-50
6
48
-58
17
-17
-2
-17
28

Gossamer Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-146
-180
-243
-234
-229
-179
-56
-170
Operating Cash Flow
-5
-51
-144
-176
-188
-187
-159
-3
-171
Investing Cash Flow
-144
-144
-147
215
-117
-1
-110
29
156
Financing Cash Flow
6
300
321
312
3
117
190
-11
6
Change in Cash
0
105
29
351
-303
-71
-79
13
-8

Global Institutional Holdings in Gossamer Bio Inc

Funds
Holdings
Geode Capital Management, LLC
2.03%
Siren, L.L.C.
2.22%
Hillhouse Capital Advisors, Ltd.
2.12%
Acadian Asset Management LLC
2.17%
FMR Inc
1.81%
See all

Insights on Gossamer Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 88.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 41.3% return, outperforming this stock by 86.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, GOSS stock has moved down by -83.7%

About Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
OrganisationGossamer Bio Inc
Headquarters3115 Merryfield Row, San Diego, CA, United States, 92121
IndustryBiotechnology
CEOMr. Faheem Hasnain
E-voting on sharesClick here to vote

Key Management of Gossamer Bio Inc

Name

Title

Mr. Christian Waage J.D.

Executive Vice President of Technical Operations & Administration

Ms. Jeanine Anthony

Senior Vice President of Marketing

Ms. Deanna Weber

Executive Vice President of Human Resources

Dr. Robert F. Roscigno Ph.D.

Senior Vice President of Clinical Development of Pulmonary Vascular Disease

Mr. Matt Cravets

Senior Vice President of Biometrics

Mr. Faheem Hasnain

Co-Founder, CEO, President & Chairman

Mr. Bryan Giraudo

COO & CFO

Ms. Caryn L. Peterson

Executive Vice President of Regulatory Affairs

Dr. Richard Aranda M.D.

Chief Medical Officer

Mr. Jeff Boerneke

General Counsel & Secretary

FAQs

What is Gossamer Bio Inc share price today?

Gossamer Bio Inc share price today is $0.42 as on at the close of the market. Gossamer Bio Inc share today touched a day high of $0.46 and a low of $0.42.

What is the 52 week high and 52 week low for Gossamer Bio Inc share?

Gossamer Bio Inc share touched a 52 week high of $3.87 on and a 52 week low of $0.32 on . Gossamer Bio Inc stock price today i.e. is closed at $0.42,which is 89.15% down from its 52 week high and 31.25% up from its 52 week low.

What is Gossamer Bio Inc's market capitalisation today?

Gossamer Bio Inc market capitalisation is $0.00T as on .

How to invest in Gossamer Bio Inc Stock (GOSS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gossamer Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gossamer Bio Inc Shares that will get you 3.5714 shares as per Gossamer Bio Inc share price of $0.42 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Gossamer Bio Inc Stock (GOSS) from India?

Indian investors can start investing in Gossamer Bio Inc (GOSS) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Gossamer Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Gossamer Bio Inc share’s latest price of $0.42 as on April 21, 2026 at 1:29 am IST, you will get 23.8095 shares of Gossamer Bio Inc. Learn more about fractional shares .

What are the returns that Gossamer Bio Inc has given to Indian investors in the last 5 years?

Gossamer Bio Inc stock has given -95.04% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?